Journal profile

Endocrine journal

Publisher: Japan Endocrine Society
ISSN0918-8959 | 1348-4540 FormatPrint StatusCurrently indexed
Official Website Verify CrossRef

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.42
Citation rate 2.83 687 total citations
h5-index 29 h5 depth signal
Cited share 69.5% 178 of 256
Total citations 687 Citation footprint
Metric signal 3.27 External metric anchor
Self-citation 2.6% 18 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

Japan 1,074
China 300
South Korea 57
United States 21
Turkey 16

Citing Fields of Research

Endocrinology & Metabolism 629
Diabetes 454
Adrenal Dysfunction 171
Endocrine Therapy 73
Osteopathies 72

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 4,482 Articles tracked across the journal lifetime
Indexed publication set 256 178 cited publications
Last 12 months 139 69.5 publications/month
Open access share 87.1% 121 OA publications in the last year
Leading citing country Japan 1,074 citing publications
Leading citing field Endocrinology & Metabolism 629 citing publications
Latest tracked publication 14 May 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v40n1, Feb.1993-
PubMed
v40n1, Feb.1993-
Index medicus
Active Coverage
PMC
Active Coverage

Research Focus & Classification

Indexed Subjects

Endocrinology & Metabolism Diabetes Adrenal Dysfunction

Issuing & Sponsoring Bodies

Contributor
Nihon Naibunpi Gakkai
Contributor
Endocrine Society of Australia

Broad Categories

Endocrinology Endocrinology & Metabolism Diabetes Adrenal Dysfunction Endocrine Therapy Osteopathies

MeSH Descriptors

Endocrinology

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

02
Open DOI
Takuya Kitamura, Kazutaka Nanba, Mutsuki Mishina et al.
The ectopic secretion of growth hormone (GH) or growth hormone-releasing hormone (GHRH) is responsible for fewer than 1% of acromegaly cases. Furthermore, within this small population, GHRH-secreting pheochromocytomas/paragangliomas (PPG...
03
Open DOI
Shogo Iwamura, Nagisa Nirei, Mari Matsuyama et al.
Werner syndrome (WS) is a rare autosomal recessive progeroid disorder caused by mutations in the WRN gene and is characterized by distinctive physical features and metabolic complications, including insulin resistance, diabetes, hypertri...
06
Open DOI
Yukino Okimoto, Akinori Takedomi, Tsuguka Matsuda et al.
Although previous studies have described steroidogenic enzyme expression in aldosterone-producing adrenocortical carcinoma (APAC), detailed immunohistochemical evaluations of CYP11B2 at the protein level and its clinicopathological relev...
07
Open DOI
Ikki Sakuma, Gerald I. Shulman, Tomoaki Tanaka
Fructose-1,6-bisphosphatase (FBPase) deficiency is a rare autosomal recessive disorder of gluconeogenesis caused by the biallelic pathogenic variants of FBP1. Recurrent episodes of hypoglycemia and lactic acidosis usually occur during ch...
08
Open DOI
Jun Mori, Akie Nakamura, Masanobu Kawai et al.
In Japan, GH treatment (GHT) is used for short stature associated with small for gestational age (SGA), Noonan syndrome (NS), Turner syndrome (TS), achondroplasia (ACH), and hypochondroplasia (HCH). However, real-world data on these diag...
10
Open DOI
Yuta Nakamura, Hiroshi Yano, Norio Abiru et al.
The coronavirus disease 2019 (COVID-19) pandemic and associated lifestyle changes have affected metabolic status in individuals with diabetes. The impact of these changes on renal function in individuals with type 1 diabetes (T1D) remain...

Bibliographical & Catalog Notes

Bimonthly.

Title from cover.

Print issues ceased with v. 65, no. 3 (2018).

Issues for 2005-2007 include supplement consisting of Proceedings of the Endocrine Society of Australia.

Also issued online.